
Pedialyte is owned by Abbott Laboratories (NYSE: ABT), the American health care company headquartered in North Chicago, Illinois. Developed by Abbott's Ross Laboratories, it was first issued to hospitals in 1966 and reached retail consumers in 1969. Pedialyte is the leading oral electrolyte solution in the United States, marketed for children and, increasingly, for adults using it for hydration, illness recovery, and hangover relief.
Parent Company
Founded
1964
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Pedialyte | Abbott Laboratories | Wholly owned |
Pedialyte was developed at Ross Laboratories in Columbus, Ohio and introduced in 1964, with first distribution to hospitals beginning in 1966. The product was designed as an oral electrolyte solution for infants and children suffering dehydration from diarrhea and vomiting, conditions that were significant causes of hospitalization before oral rehydration became standard practice.
Non-hospital retail sales began in 1969. For decades Pedialyte was positioned strictly as a pediatric medical product, sold in the pharmacy aisle alongside other baby and child health items. That positioning held until the 2010s, when Abbott observed that adults were buying the product for illness recovery, athletic hydration, and hangover relief.
Rather than resist the adult use case, Abbott embraced it. The company launched Pedialyte products formulated and marketed for adults, expanded into powder stick packs, freezer pops, and sport variants, and signed athlete ambassadors including NFL wide receiver Odell Beckham Jr. The repositioning turned Pedialyte into one of Abbott Nutrition's fastest-growing consumer brands.
The adult hydration market Pedialyte moved into became crowded in the 2020s, with Liquid IV, Nuun, and LMNT competing on electrolyte content and lifestyle marketing. Pedialyte retained its lead on the strength of medical positioning and retail presence in the pharmacy channel, though its share of the expanding category faces more competition than the pediatric franchise ever encountered.
As of 2026 Pedialyte continues under Abbott Nutrition, part of a segment that contributed $2.14 billion in Q2 2026 sales, with the brand's adult variants representing the growth edge of the line.
What does Abbott Laboratories own?
Abbott Laboratories owns brands across nutrition (Similac, Ensure, PediaSure, Pedialyte), medical devices (FreeStyle Libre, Volt, TactiFlex, Amulet), and diagnostics (Cologuard, BinaxNOW, Alinity). The company acquired Exact Sciences in March 2026 for $21 billion, adding Cologuard and other molecular diagnostic products.
Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories trades on the New York Stock Exchange under the ticker symbol ABT. The company has been publicly listed since 1929 and is a component of the S&P 500 Index.
Who founded Abbott Laboratories?
Abbott was founded in 1888 by Dr. Wallace Calvin Abbott, a physician in Ravenswood, Illinois (now part of Chicago). He began by manufacturing reliable dosimetric granules for pharmaceutical use.
Where is Abbott Laboratories headquartered?
Abbott is headquartered in Abbott Park, North Chicago, Illinois, USA. The company operates in more than 160 countries globally.
How many brands does Abbott Laboratories own?
Abbott owns numerous brands across its four segments. Key consumer brands include Similac, Ensure, PediaSure, and Pedialyte in nutrition. Key medical device brands include FreeStyle Libre, Volt, and Amulet. Key diagnostics brands include Cologuard, BinaxNOW, and Alinity.
Who owns Abbott Laboratories?
Abbott Laboratories is a publicly traded company with shares held by institutional investors, mutual funds, and individual shareholders. The company is led by Chairman and CEO Robert B. Ford.
What is Abbott Laboratories' revenue?
Abbott reported Q2 2026 sales of $12.59 billion, up 13.0% on a reported basis and 4.8% on a comparable basis. The company reaffirmed full-year 2026 comparable sales growth guidance of 6.5% to 7.5% and raised adjusted diluted EPS guidance to $5.45 to $5.60.
Did Abbott acquire Exact Sciences?
Yes, Abbott completed the $21 billion acquisition of Exact Sciences in March 2026. The acquisition added Cologuard, a noninvasive colorectal cancer screening test, to Abbott's diagnostics portfolio. Diagnostics sales grew 42% year over year in Q2 2026, the first full quarter including Exact Sciences results.
Abbott has committed to science-based emissions targets and reports on packaging improvements across its nutrition brands. Pedialyte does not hold independent third-party sustainability certifications, and Abbott is not a Certified B Corporation.
The product itself is a medical-grade hydration solution, and its ethical considerations are primarily about appropriate use and marketing. Abbott states that Pedialyte marketing complies with applicable regulations. The brand's expansion into adult hangover and lifestyle marketing has drawn periodic commentary from health writers about whether medical positioning is being stretched, though no regulatory action has resulted.
2022 Abbott nutrition recall context: Abbott's voluntary February 2022 recall of powdered products from its Sturgis, Michigan plant covered Similac, Alimentum, and EleCare, not Pedialyte. The event nonetheless subjected Abbott's nutrition manufacturing to heightened FDA oversight and affected consumer perception across the division.
Hangover marketing scrutiny: Pedialyte's embrace of adult hangover relief marketing has drawn occasional criticism from health commentators who argue medical branding is being applied to lifestyle use. Abbott maintains the product's formulation is appropriate for adult dehydration and has faced no regulatory enforcement over the positioning.
Routine quality matters: As with any mass consumer product, Pedialyte has experienced occasional isolated quality complaints and packaging issues over the decades, none rising to a major brand-level recall.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Abbott Laboratories | USA | 1973 | Mass market | Global | All-ages | |
| Keurig Dr Pepper | USA | 2015 | Premium | United states | All Genders | |
| Coca Cola Company | USA | 1996 | Mass market | Global | All-ages | |
| Abbott Laboratories | USA | 2003 | Premium | United states | All-ages | |
| Abbott Laboratories | USA | 1988 | Mass market | Global | All-ages |
Healthcare PharmaceuticalsOwned by Abbott Laboratories
American adult nutrition shake brand owned by Abbott Laboratories, introduced in 1973 and sold in more than 160 countries as a complete nutritional supplement.
Food BeverageOwned by Keurig Dr Pepper
Premium purified water with balanced pH and added electrolytes, owned by Keurig Dr Pepper.
Food BeverageOwned by The Coca-Cola Company
American enhanced water brand featuring vapor-distilled water with added vitamins, minerals, and natural flavors, known for its colorful packaging and health-focused positioning.
Baby CareOwned by Abbott Laboratories
Amino acid-based hypoallergenic infant and child formula brand owned by Abbott Laboratories, launched in 2003 for severe protein allergies and manufactured at Abbott's Sturgis, Michigan facility.
Baby CareOwned by Abbott Laboratories
Children's nutritional supplement drink brand owned by Abbott Laboratories, launched in 1988 and marketed for children ages 1 to 13 needing supplemental nutrition.
Market Positioning: Pedialyte competes with 5 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Abbott Laboratories, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
Boots is privately owned, unlike Pedialyte which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
Duane Reade is privately owned, unlike Pedialyte which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike Pedialyte which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.
Walgreens is privately owned, unlike Pedialyte which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
Tirosint is privately owned, unlike Pedialyte which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by GoodRx Holdings, Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
GoodRx operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.